Published in Epilepsy Res on September 11, 2007
Migraine attack triggering a generalised seizure: is this a case of migralepsy or ictal epileptic headache? Neurol Sci (2011) 0.80
Commentary on the usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy. Epilepsy Res (2008) 0.75
Electroencephalography in the Diagnosis of Genetic Generalized Epilepsy Syndromes. Front Neurol (2017) 0.75
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol (2011) 3.36
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol (2011) 2.44
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32
Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology (2012) 2.18
Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia. Ann Neurol (2002) 2.07
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet (2003) 1.99
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain (2012) 1.67
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. J Neurol Sci (2007) 1.61
Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease. Mov Disord (2011) 1.56
UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol (2004) 1.54
Familial mesial temporal lobe epilepsy (FMTLE) : a clinical and genetic study of 15 Italian families. J Neurol (2007) 1.54
Progressive myoclonic epilepsies: definitive and still undetermined causes. Neurology (2014) 1.52
Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy. Mov Disord (2008) 1.48
Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet (2012) 1.48
Compound heterozygosity in DJ-1 gene non-coding portion related to parkinsonism. Parkinsonism Relat Disord (2008) 1.45
Blocking out the real diagnosis. Lancet (2011) 1.43
Modulatory proteins can rescue a trafficking defective epileptogenic Nav1.1 Na+ channel mutant. J Neurosci (2007) 1.43
Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol Psychiatry (2005) 1.41
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol (2011) 1.40
Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol (2004) 1.40
Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study. J Neuroimmunol (2010) 1.39
Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proc Natl Acad Sci U S A (2005) 1.32
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Ann Neurol (2005) 1.29
Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study. Mov Disord (2011) 1.27
Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task. Mov Disord (2011) 1.23
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. Clin Neuropharmacol (2004) 1.14
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging (2012) 1.13
Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord (2011) 1.11
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. Hum Mutat (2013) 1.10
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol (2004) 1.10
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord (2008) 1.08
Which is the goal of cognitive rehabilitation in multiple sclerosis: the improvement of cognitive performance or the perception of cognitive deficits? Mult Scler (2013) 1.07
Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurol Sci (2012) 1.06
Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Arch Neurol (2005) 1.06
Comparison of different MR venography techniques for detecting transverse sinus stenosis in idiopathic intracranial hypertension. J Neurol (2005) 1.05
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? Neurosci Lett (2004) 1.04
Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. Epilepsy Res (2008) 1.04
Clinical and genetic findings in 26 Italian patients with Lafora disease. Epilepsia (2006) 1.03
Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report. Seizure (2010) 1.02
Neocortical thinning in "benign" mesial temporal lobe epilepsy. Epilepsia (2011) 1.02
Consensus on diagnosis and management of JME: From founder's observations to current trends. Epilepsy Behav (2013) 1.01
Benign mesial temporal lobe epilepsy. Nat Rev Neurol (2011) 1.00
The gender effect in juvenile Huntington disease patients of Italian origin. Am J Med Genet B Neuropsychiatr Genet (2004) 0.99
Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology (2012) 0.99
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]. Pharmacol Res (2006) 0.99
Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study. Am J Med Genet B Neuropsychiatr Genet (2010) 0.99
Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A. J Peripher Nerv Syst (2008) 0.97
Altered cortical-cerebellar circuits during verbal working memory in essential tremor. Brain (2011) 0.96
Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume. Neuroreport (2008) 0.96
Voxel-based morphometry of sporadic epileptic patients with mesiotemporal sclerosis. Epilepsia (2009) 0.96
Anti-NMDA receptor encephalitis: a video case report. Epileptic Disord (2009) 0.96
Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates. Neurorehabil Neural Repair (2012) 0.95
Neuroanatomic correlates of psychogenic nonepileptic seizures: a cortical thickness and VBM study. Epilepsia (2011) 0.95
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol Aging (2009) 0.95
Body weight influences pharmacokinetics of levodopa in Parkinson's disease. Clin Neuropharmacol (2002) 0.95
Genetically dependent modulation of serotonergic inactivation in the human prefrontal cortex. Neuroimage (2007) 0.94
Sporadic ALS is not associated with VAPB gene mutations in Southern Italy. J Negat Results Biomed (2006) 0.94
Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease. Brain Res Bull (2007) 0.93
The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study. Behav Brain Res (2009) 0.93
Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern. Mov Disord (2006) 0.92
Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis. Brain (2009) 0.92
Neuroimaging of Essential Tremor: What is the Evidence for Cerebellar Involvement? Tremor Other Hyperkinet Mov (N Y) (2012) 0.92
Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study. Seizure (2006) 0.91
Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsy. Epilepsia (2007) 0.91
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet (2012) 0.90
Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study. Mov Disord (2010) 0.90
MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology (2006) 0.90
Ventro-lateral prefrontal activity during working memory is modulated by MAO A genetic variation. Brain Res (2008) 0.89
Two novel SCN1A missense mutations in generalized epilepsy with febrile seizures plus. Epilepsia (2003) 0.89
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiol Aging (2013) 0.89
A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation. J Neurol (2008) 0.89
Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study. Neurol Sci (2014) 0.89
Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. Neurol Sci (2008) 0.89
Spinal glioneuronal tumor with neuropil-like islands and meningeal dissemination: histopathological and radiological study of a pediatric case. Neuropathology (2008) 0.88
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study. Mov Disord (2007) 0.88
Automatic Detection of White Matter Hyperintensities in Healthy Aging and Pathology Using Magnetic Resonance Imaging: A Review. Neuroinformatics (2015) 0.88
Brain iron deposition in essential tremor: a quantitative 3-Tesla magnetic resonance imaging study. Mov Disord (2012) 0.88
Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine. Epilepsia (2013) 0.88
Electroclinical features of a family with simple febrile seizures and temporal lobe epilepsy associated with SCN1A loss-of-function mutation. Epilepsia (2007) 0.88